Smart contact lenses incorporate a diversity of thin‐film components and are also fabricated
utilizing different thin films. They have been developed for the sensing and treatment of …

Because of their unique capacity for differentiation to a diversity of cell lineages and
immunosuppressive properties, mesenchymal stem cells (MSC) are being looked at as a …

Background Allo-HSCT is a definite approach for the management of a wide variety of lethal
and debilitating malignant and non-malignant disorders. However, its two main …

Graft versus host disease (GVHD) remains a major and serious complication of allogeneic
hematopoietic stem cell transplantation. Based on the time of onset, clinical phenotypes …

Background: Chronic ocular graft-versus-host disease (oGVHD) is a common ocular
complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT) …

Purpose To investigate the delayed diagnosis of chronic ocular graft-versus-host disease
(coGVHD) after allogeneic hematopoietic stem cell transplantation (alloHCT), and further …

Ocular graft-versus-host disease (oGVHD) affects~ 50% of post-stem cell transplant patients
and is the only form of GVHD diagnosed without a biopsy. As it must be distinguished from …

Hematopoietic stem cell transplantation (HSCT) has benefited an increasing number of
patients with hematological disease in the clinic. It is a curative therapy for malignant and …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative strategy against
a variety of malignant and nonmalignant disorders. However, acute and chronic graft-versus …

Abstract Ocular Graft-versus-Host Disease (oGVHD) remains a challenging and potentially
devastating complication following allogeneic hematopoietic stem cell transplantation (allo …